FDA issued a Warning Letter to Genzyme Corporation on 2/27/2009 as a result of this inspection.
FDA investigators audited the Sanofi Genzyme - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 10 Oct 2008.
Add To Cart
- Category: Human Drugs
- Inspection end: 10 Oct 2008
- Location: Cambridge, United States
- FEI: 1000305672